JANX - Janux Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

JANX is currently covered by 7 analysts with an average price target of $77.11. This is a potential upside of $41.1 (114.13%) from yesterday's end of day stock price of $36.01.

Janux Therapeutics's activity chart (see below) currently has 3 price targets and 35 ratings on display. The stock rating distribution of JANX is 90.91% BUY and 9.09% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 49.55% with an average time for these price targets to be met of 275.14 days.

Highest price target for JANX is $200, Lowest price target is $48, average price target is $77.11.

Most recent stock forecast was given by JOSH SCHIMMER from CANTOR FITZGERALD on 11-Dec-2024. First documented stock forecast 06-Jul-2021.

Currently out of the existing stock ratings of JANX, 30 are a BUY (90.91%), 3 are a HOLD (9.09%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$200

$163.99 (455.40%)

$200

2 months 11 days ago
(11-Dec-2024)

1/7 (14.29%)

$136.55 (215.21%)

966

Hold

$62

$25.99 (72.17%)

$42

2 months 18 days ago
(04-Dec-2024)

3/3 (100%)

$-4.84 (-7.24%)

7

Buy

$70

$33.99 (94.39%)

$63

2 months 19 days ago
(03-Dec-2024)

10/11 (90.91%)

$10.14 (16.94%)

252

Buy

$115

$78.99 (219.36%)

$70

2 months 19 days ago
(03-Dec-2024)

0/2 (0%)

$55.14 (92.11%)

Buy

$105

$68.99 (191.59%)

$70

2 months 19 days ago
(03-Dec-2024)

0/2 (0%)

$45.14 (75.41%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is JANX (Janux Therapeutics) average time for price targets to be met?

On average it took 275.14 days on average for the stock forecasts to be realized with a an average price target met ratio 49.55

Which analyst has the current highest performing score on JANX (Janux Therapeutics) with a proven track record?

SWAYAMPAKULA RAMAKANTH

Which analyst has the current lower performing score on JANX (Janux Therapeutics) with a proven track record?

SOUMIT ROY

Which analyst has the most public recommendations on JANX (Janux Therapeutics)?

Swayampakula Ramakanth works at HC WAINWRIGHT and has 5 price targets and 6 ratings on JANX

Which analyst is the currently most bullish on JANX (Janux Therapeutics)?

Josh Schimmer with highest potential upside - $163.99

Which analyst is the currently most reserved on JANX (Janux Therapeutics)?

Geoff Meacham with lowest potential downside - $11.99

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?